Cancer - Cause & Cure

The Cause

A partial list of scientists having identified a pleomorphic organism as the causative agent in cancer and allied pathologies is herein set forth. A summary list of proponents contributing to Delta’s current success will prove useful :

William Russel Russell Bodies
Thomas Glover Filterable Forms
William Frederick Koch Chemical isolation of filterable forms
Royal Raymond Rife Microscopy isolation and radio assisted destruction of filterable forms
Virginia Livingston Wheeler Culture techniques for filterable forms
Irene Diller  
Elenor Jackson  
Von Brehmer  
George A. Clark  

The organism responsible for cancer shall be referenced as a stealth bacterium to distinguish it from detectible viral colonies whose primary damage stems from their ability to rapidly replicate. Conversely, the stealth bacterium replicates slowly, thus producing low bacterial populations making the stealth bacterium difficult for researchers to isolate. A population of one (1) stealth bacterium is all that is required to construct a cancer cell.  The pathogen impairs cellular respiration through manipulating cellular energy and nutrition.  

Put simply, cancer is caused by a bacterium that impairs the cells ability to use oxygen.

Properties of the stealth bacterium include

•           Activated amine group chemistry
•           Pleomorphic: (changes forms) 
•           Cell wall deficient
•           Small (filterable at .05 microns)
•           Highly motile
•           Thermal death point (107.8)
•           Aerobic (oxygen loving)
•           Highly pathogenic
•           Not effected by x-rays, ultra violet, or infra-red.
•           Low rate of binary fission

The method of impairment

In 1924 Nobel laureate Otto Heinrich Warburg hypothesized that cancer was caused by impaired oxidation at the cellular level.  He observed that cancer cells produced energy by way of fermenting glucose, even when an abundance of molecular oxygen was present. Conversely, healthy cells generate energy from the oxidative breakdown of glucose in the form of pyruvate.  The fermentation of pyruvate in the absence of oxygen is this illustrated:

As significant as Warburg’s discoveries were, he did not succeed in identifying the specific mechanism of impairment.  Delta understands cancer as a mitochondrial dysfunction and has explained in considerable detail the specific chemistry relating to both causation and remedial action.  Delta has demonstrated, in great specificity, that the pathogenesis of cancer begins with the amine group of synthetic carcinogens or of a specific fungus that gels the blood in a manner that reduces oxygen supply to the vital areas of cellular respiration. This “disposing factor” prepares the way for the stealth bacterium which in turn locks down cellular respiration by forming bonds with carbonyl groups that are the cellular engines that initiate the oxidation of glucose.

The Cure

The cure for cancer and a host of other degenerative pathologies is found in neutralizing the bacterial chemistry, or other constituents that may be responsible for impairing the cells ability to utilize oxygen and produce energy.  Any viable therapy must restore the ability of the mitochondria to "initiate" oxidative chains, thereby restoring mitochondrial function.


1890 Russel finds fuschin staining particles or bodies in cancer cells.
     ["An address on a characteristic organism of cancer". Brit.Med.J. 2:
     1356-1360, 1890. Later referred to as "Russel bodies", sometimes
     larger than rbc.]

1898 Sanfelice points out correspondence of blastomyces with cancer [a genus
     of protophytes; the yeast fungi]

1899 Joseph Koch finds parasitic inclusions in cancer he names protozoan
     Cancrosum--also outside cancer cell.

1901 Van Leyden describes "birdseye cells"

1902 [Beard, J, publishes first paper on trophoblastic thesis
     of cancer:Lancet 1:1758, 1902.]

1902 Barel suggests a virus activated by parasites.

1903 Otto and Wolfgang Schmidt discover "vermicules" and spores in cancer.

1904 Doyen reports cocci and chains in cancer.

1905 [Beard, J, reports on embryological grounds the antithesis
     of the pancreatic enzymes to the trophoblast cell:
     Lancet 1:281, 1905.]

1911 [Rous reported the transmission of a sarcoma in a Plymouth Rock hen by
     cell-free filtrates.]

1914 Mori (Naples) describes his theory of the mycetic nature of ultra-virus
     which he witnessed transform pleomorphically in 1910.

1920 Enderlein describes his cancer-associated "Endobiont".

1921 [Young, J., publishes: "Description of an organism obtained from
     carcinomatous growths" Edinburgh Med.J. (New series) 27:212-221, 1921.]

1921 [Nuzum, J.W.publishes: "A critical study of an organism associated with
     a transplantable carcinoma of the white mouse." Surg. Gynecol.Obstet.
     33: 167-175, 1921.]

1925 [Young, J.: An address on a new outlook on cancer: Irritation and
     infection. Brit.Med.J., Jan 10, 1925, pp 60-64.]

1925 [Scott, M.J.: The parasitic origin of carcinoma. Northwest Med.
     24:162-166, 1925.]

1925 [Scott, M.J.: More about the parasitic origin of malignant epithelial
     growths. Northwest Med. 25: 492-498, 1925.]

1925 [Nuzum, J.W.:The experimental production of metastasizing carcinoma in
     the breast of the dog and primary epithelioma in man by repeated
     inoculation of a micrococcus isolated from human breast cancer.
     Surg.Gynecol.Obstet 11:343-352, 1925].

1925 [Lewin, C. publishes: "Invisibles Virus und maligne Geschwulste."
     Ztschr.f.Krebsforsch. 22:455.]

1926 [Leitch, A.: Dr Young's cancer parasite. Brit. Med.J., April 17, 1926,
     page 721.]

1926 Tissot describes parasitic amoeboid forms in cancer.

1928 Heidenhein (Tubingen) delineates histologically traceable microbe in

1929 [Stearn, E.W., Sturdivant BF, and Stearnd, AE: The ontogeny of an
     organism isolated from malignant tumors. J.Bact. 18:227-245, 1929.]

1930 [Glover, T.J., The bacteriology of cancer. Canada Lancet Pract. 75:
     92-111, 1930.]

1931 [Rife finds cancer virus in breast tumor, names "Bacillus X".]

1932 Von Neergard reports blood parasites.

1932 Von Brehmer describes cancer as virus disease agent: Siphanospora
     polymorpha (published by Br.Linck, Haag/Amper.)(sic)

1932 Nebel bred various growths from cancer blood, and called his virus
     as "onkomyxa neoformans".

1933 Dechow points out aspergillus in cancer.

1933 Gruner and Glower also find a fungus, which along with Rife, name
     "Cryptomyces pleomorpha".

1933 [Shope (2) demonstrated a virus responsible for cutaneous
     papillomas in western cottontail rabbits.]

1934 [Von Brehmer, W.: Siphonospora polymorpha, n.sp., neuer Mikrooganismus
     des Blutes und seine Beziehung zur Tumorgenese. Med.Welt 8:1179-1185,

1938 [Lucke (3) reported that a spontaneous renal carcinoma in the
     leopard frog is probably caused by a virus.]

1941 [Mazet, G.: Etude bacteriologique sur la malade d'Hodgkin. Montpellier
     Med. 1941: 316-328, 1941.]

1942 [Bittner finds a filterable agent with many of the characteristics
     of a virus: "mammary tumor agent" influencing development
     of mammary carcinoma in susceptible strains of mice. [Bittner virus]]

1942 [Needham, J, criticizes wholesale reliance on viral thesis of
     carcinogenesis: Biochemistry and Morphogenesis, Cambridge
     Univ.Press, 1942, p.268.]

1948 F.Gerlach publishes "Krebs und obligaten Pilzparasitismus" (Cancer
     and Obligatory fungus-parasitism), Vienna.

1949 [Mann and Dunn publish Propagation of mouse carcinoma by dried tumor
     tissue. Brit. Med. J. 2: 255, 1949.]

1949 [Gye, W.E. The propagation of mouse tumors by means of dried tissue.
     Brit. Med. J. 2:1485.]

1950 [Krebs, Jr., et al. publish The Unitarian or Trophoblastic Thesis
     of Cancer, Medical Record, 163:149-174 (1950). Define the role
     of virus as "specialized contributory means of eliciting
     malignant differentiation". But maintain outcome is still

1950 [Duran-Reynals publishes Neoplastic infection and cancer. Am.J.Med.

1950 [Wuerthele Caspe (Livingston), V., Alexander-Jackson, E., Anderson,
     J.A., et al.: Cultural properties and pathogenicity of certain
     microorganisms obtained from various proliferative and neoplastic
     diseases. Amer.J.Med.Sci. 220: 628-646, 1950.]

1951 Lea Del Bo Rossi publishes microphotographs of tiniest fungus particles
     found in cancer.

1951 [Fox publishes "Virus-like bodies in human cancer. An
     electron-microscope study of normal and neoplastic tissue". Cancer

1952 [Stasney, Cantarow, and Paschkis publish "Production of neoplasms
     by injection of fractions of mammalian neoplasms." Ann. New York Acad.
     Sci. 54: 1177, 1952.]

1952 [Miner, Editor, publishes.Viruses as causative agents in cancer." Ann.
     New York Acad. Sci. 54: 869-1232.]

1954 [Alexander-Jackson, E.: A specific type of microorganism isolated
     from animal and human cancer:Bacteriology of the organism. Growth 18:
     37-51, 1954.]

1955 [Terrel, T.C, and Beard, H.H., publish: A Biochemical Test for
     Chorionic Gonadotrophin in the Urine and Its Value as an Aid
     in the Diagnosis of Pregnancy and Malignancy, South.M.J. 48:
     1352-1360 (1955)]

1956 Scheller publishes "Von Viren, Mitochondrian und vom Krebs"
     (On Viruses, Mitochondria, and Cancer).

1957 Stanley at Berkeley discusses virology in relation to cancer.

1958 Clara Fonti, Milan, publishes "Aetiopathogeneses des Krebs"
     (Etiopathogenesis of Cancer), asserting parasitic origins of cancer

1958 Schilling succeeds in inducing cancer with Siphonaspora rods.

1960 [Boesch, M.: The Long Search for the Truth about Cancer, GP Putnam's
     Sons, New York, 1960.]

1962 [Diller, IC: Growth and morphological variability of pleomorphic,
     intermittently acid-fast organisms isolated from mouse, rat and
     human malignant tissues. Growth 26: 181-209, 1962.]

1970 G. Sauer publishes "Viruses as accomplices in Cancer, Research on
     New Paths", finds papilloma viruses strongly indicated (papova v.)
     German Cancer Research Institute, Heidleberg, Pub'd in Bilden
     der Wissen, Feb.1973.

1970 R.Sklenar developes blood pictures technique to show predisposition
     for cancer.

1972 [Seibert, F.B., Yeomans, F., Baker, J.A., et al.: Bacteria in tumors.
     Trans. NY Acad.Sci. 34(6):504-533, 1972.]

1974 [Mattman, L.H.:Cell Wall Deficient Forms, CRC Press, 1974.]

1974 [Mazet, G.: Corynebacterium, tubercle bacillus, and cancer. Growth
     38: 61-74, 1974.]

1974 [Wuerthele Caspe Livingston, V. Livingston, A.M.: Some cultural,
     immunological, and biochemical properties of Progenitor cryptocides.
     Trans. NY Acad. Sci. 36(6):569-582, 1974.]

1977 [Livingston-Wheeler, VWC, Wheeler, OW: The Microbiology of
     Cancer. Livingston Wheeler Medical Clinic Pub.,San Diego,1977.]

1978 [Acevedo, H.F., Slifkin, M., Pouchet, G.R., et al.: Immunohisto-
     chemical localization of a choriogonadotropin-like protein in bacteria
     isolated from cancer patients. Cancer 41:1217-1229, 1978.]

1981 [Cantwell, A.R.Jr.,Kelso, D.W.:Microbial findings in cancers
     of the breast and in their metastases to the skin. J.Dermatol.
     Surg.Oncol. 7:483-491,1981.]

1981 [Cantwell, AR Jr.:Histologic observations of variably acid-fast
     coccoid forms suggestive of cell wall deficient bacteria in
     Hodgkin's disease. A report of four cases. Growth 45:168-187,

1981 Weber, Erding, West Germany, isolated and cultivated "cancer
     protozoa" in chicken eggs.

1981 Mordes and Rossini find cancer causing agent/chemical in blood. Using
     tumor free rats in parabiosis with cancerous rats, caused tumors in
     the former. Science, Vol. 213, p.565.

1982 [Domingue, G.J.(Ed.): Cell Wall Deficient Bacteria. Basic
     Principles and Clinical Significance. Addison Wesley, 1982.]

1984 Bishop, Varnus (San Francisco) and Gallo, (Bethesda) triggered cancer
     with virus, "Artzliche Praxis", Sept 8, 1984, p.1980.

1996 [Panno et al. find that cancer (MCF-7 cell-line) becomes quiescent
     in fetal-calf steroid free serum...the diametric opposite of
     pathological behaviour (non-cell-line). Thus, w/o intent, prove
     cell-line research is useless. J.Ca.Res.Clin.Oncol. 122:745-749.:)]